Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03831516 · ClinicalTrials.gov registry record
Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 30
- Enrollment target
NCT03831516: Completed study, sponsored by Northwell Health.
NCT03831516 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03831516 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study will measure the diagnostic sensitivity and specificity of the Medtronic CardioInsight wearable 252 electrode vest in predicting the chamber of origin of premature ventricular complexes (PVCs) and compare its diagnostic accuracy with the standard 12- lead ECG.
Primary Outcome
Measure the diagnostic sensitivity and specificity of non-invasive mapping system in predicting origin of spontaneous ventricular arrhythmias in patients undergoing EPS
Interventions
- DIAGNOSTIC_TEST Non Invasive Electroanatomical Mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2022-03-01 |
What the finished NCT03831516 record still lists
NCT03831516 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non Invasive Electroanatomical Mapping is the first listed.
NCT03831516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03831516 about?
NCT03831516 is a clinical study titled "Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias". This study will measure the diagnostic sensitivity and specificity of the Medtronic CardioInsight wearable 252 electrode vest in predicting the chamber of origin of premature ventricular complexes (PVCs) and compare its diagnostic accuracy with the standard 12- lead ECG.
What is the current status of trial NCT03831516?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-01-04. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT03831516?
The interventions under investigation include: Non Invasive Electroanatomical Mapping (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03831516?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI